Monthly Archives: January 2011

Nanoparticle Treatment in Development

Researchers are working with industry partners to create a medical device that would “use magnetic nanoparticles engineered to capture cancer cells. Added to fluids removed from a patient’s abdomen, the magnetic nanoparticles would latch onto the free-floating cancer cells, allowing … Continue reading 

Posted in News | Tagged , | Leave a comment

Board President Annette Leal Mattern Remembers Jack LaLanne

I never imagined meeting workout icon Jack LaLanne. After all, I was only five years old when he swam, handcuffed, from Alcatraz to San Francisco’s Fisherman’s Wharf. I vaguely remembered seeing his TV program when I was just a kid. … Continue reading 

Posted in Blog | 1 Comment

Unrealistic Optimism in Early-Phase Oncology Trials

A new report questions the ethics of early stage oncology clinical trials, asserting that since patients have unrealistically high expectations of the outcomes of the trials, a question of informed consent is raised.  According to the LA Times, 60% were … Continue reading 

Posted in News | Tagged , | 1 Comment

Closeout Sale on Dolce Vita Believe Candles

From now until midnight on January 31, 2011, Dolce Vita is offering a closeout deal on their “Believe” candles. Buy two candles at the discounted price of $50 each and receive an additional two candles free! Quantities are limited. Buy … Continue reading 

Posted in Blog | 2 Comments

ASCO Recommends Steps to Improve Doctor-Patient Communication about End-of-Life Cancer Care

The American Society of Clinical Oncology released a policy statement recommending “steps to ensure that physicians initiate candid discussions about the full range of palliative care and treatment options soon after patients’ diagnosis with advanced cancer (defined as incurable disease).” … Continue reading 

Posted in News | Tagged , | Leave a comment

‘Rogue gene’ discovery could brake cancers

Researchers have found that by blocking the activity of a certain gene, WWP2, cancer cells can be prevented from spreading.  At this point, there is no drug that could inhibit this mechanism. Read the full article here

Posted in News | Tagged , , | 1 Comment

Upcoming Webinar: Young Survivors Rock!

Lindsay Avner, Founder and Executive Director, Bright Pink Chana Garcia, advocate, blogger and ovarian cancer survivor Click here to register.

Posted in Events | Leave a comment

Third Annual Teal Ribbon Golf Tournament Raises Funds, Awareness

The sky was filled with Teal on Thursday, January 13, 2011 as the Ovarian Cancer Alliance of Arizona (OCAZ) kicked off its 3rd Annual Teal Ribbon Golf Tournament with an impressive teal balloon launch. Over 200 participants packed the Sun … Continue reading 

Posted in Blog | Leave a comment

Fewer Cancer Patients May Be Depressed Than Previously Thought

A study shows that one-sixth of cancer patients suffer depression one-third of cancer patients show signs of having a mood disorder See the NCI’s web page for information on depression See the article summary here

Posted in News | Tagged | Leave a comment

Many Cancer Patients Have Chronic Pain

A new study released shows that more than 40 percent of cancer patients have pain women and black have a higher risk of experiencing pain both cancer surgery and cancer treatment contributed to patients feeling pain See the full article here

Posted in News | Tagged , , | 1 Comment

Chemosensitivity Assays for Ovarian Cancer

Point: Chemosensitivity Assays Have a Role in the Management of Recurrent Ovarian Cancer In this era of personalized medicine, patients with recurrent ovarian cancer deserve better than the 25% response rate that is associated with drugs selected based on clinical … Continue reading 

Posted in News | Tagged , , | 1 Comment

Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers (JNCI)

Background Germline mutations in the BRCA1 and BRCA2 genes are associated with increased risks of breast and ovarian cancers. Although several common variants have been associated with breast cancer susceptibility in mutation carriers, none have been associated with ovarian cancer … Continue reading 

Posted in News | Tagged , | 1 Comment